← Evidence map

ReviewOncotarget2014

Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.

Angelika Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25333255